These findings highlight semaglutides potential as an effective tool for weight management in obese patients.
Manufacturers have a legal duty to warn consumers about known and foreseeable dangers associated with their products
Prabhu D, Rajamanikandan S, Sureshan M et al (2021) Modelling studies reveal the importance of the C-terminal inter motif loop of NSP1 as a promising target site for drug discovery and screening of potential phytochemicals to combat SARS-CoV-2
The mechanism behind semaglutide involves slowing gastric emptying and sending signals to the brain to induce a feeling of fullness, thereby naturally minimizing food intake
Agents in this group include peroxisome proliferator-activated receptor agonists (e.g., pioglitazone, elafibranor, saroglitazar), bile acid-farnesoid X receptor axis regulators (obeticholic acid), de novo lipogenesis inhibitors (aramchol, NDI-010976), and fibroblast growth factor 21/19 analogs